Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sprifermin in Knee Osteoarthritis
NCT01919164Phase 2Completed
- Sponsor
- EMD Serono
- Start
- Jul 2013
- Primary completion
- May 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
Phase 2, randomised, double-blind trial of sprifermin in osteoarthritis (OA) (5 arms), sponsored by EMD Serono. Primary endpoint: Change From Baseline in Cartilage Thickness in the Total Femorotibial Joint at 2 years. Started Jul 2013; status: completed.
02
Drugs
sprifermin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01919164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01919164.